Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$103K Sell
4,724
-5,957
-56% -$109K 0.06% 261
2022
Q1
$225K Buy
10,681
+4,389
+70% +$103K 0.06% 304
2021
Q4
$199K Sell
6,292
-3,332
-35% -$122K 0.05% 333
2021
Q3
$343K Sell
9,624
-2,471
-20% -$102K 0.08% 256
2021
Q2
$544K Sell
12,095
-143
-1% -$5.73K 0.12% 169
2021
Q1
$477K Sell
12,238
-6,248
-34% -$318K 0.14% 154
2020
Q4
$901K Buy
18,486
+10,126
+121% +$392K 0.27% 97
2020
Q3
$177K Sell
8,360
-17,640
-68% -$272K 0.05% 219
2020
Q2
$201K Buy
26,000
+13,000
+100% +$57.1K 0.05% 211
2020
Q1
$36.1K Buy
+13,000
New +$48.4K 0.01% 379

Other funds holding NIO

Exane Derivatives's NIO Position: Q2 2022 in Review

Exane Derivatives reduced its NIO (NIO) stake by 56% in Q2 2022, selling an estimated $109K and leaving 4,724 shares worth $103K. The position accounts for 0.06% of the portfolio, ranked #261.

Exane Derivatives first reported a position in NIO in Q1 2020 and has held it in 10 quarters since. The position peaked at $901K in Q4 2020. 544 funds tracked by Wall St. Rank hold NIO as of Q2 2022.

  • Exane Derivatives held 4,724 shares of NIO worth $103K as of Q2 2022.
  • Exane Derivatives sold 5,957 NIO shares in Q2 2022, an estimated $109K.
  • NIO made up 0.06% of Exane Derivatives's portfolio in Q2 2022, its #261 holding.
  • Exane Derivatives first reported a position in NIO in Q1 2020 and has held it in 10 quarters since.
  • Exane Derivatives's NIO position peaked at $901K in Q4 2020.
  • 544 funds tracked by Wall St. Rank held NIO as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.